Madhusubramanian Muthukumar
Research Fellow in Modelling for Health Economics and Public Health
M.Muthukumar@exeter.ac.uk
South Cloisters
South Cloisters, University of Exeter, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK
Overview
Madhusubramanian has a background in biotechnology and pursued masters in operational research and management science at Lancaster University. His interest in health economic modelling started with the dissertation work at Liverpool School of Tropical Medicine (LSTM), where he performed the discrete event simulation for modelling blood transfusion services in low- and middle-income countries. Over 6 years of experience across consulting and industry, he has led the development of economic evaluation of health care interventions including, but not limited to: cost effectiveness, budget impact and multi-criteria decision analysis (MCDA) models from conceptualisation to implementation across different disease areas such as Cervical dystonia, Asthma, Allergic rhinitis, Idiopathic pulmonary fibrosis, Schizophrenia and Bipolar mania.
In his current role as a Research Fellow in Modelling for Health Economics and Public health at PenTAG, Madhusubramanian undertakes the health technology assessment (HTA) of healthcare interventions, focusing especially on the critique of economic models for The National Institute for Health and Care Excellence (NICE).
Qualifications
- Bachelor of Technology in Biotechnology (Hons.)
- Master of Science in Operational Research and Management Science (Merit)
Research group links
Research
Research interests
- Health economic modelling
- Health Technology Assessment
- Methods for economic evaluation of healthcare interventions
- Discrete event simulation
Research projects
- NICE STA: Vamorolone for treating Duchenne muscular dystrophy
- NICE EVA: Digital technologies to support the delivery of pulmonary rehabilitation for adults with COPD
- NICE PATT: Renal cell carcinoma pathways pilot
- NICE STA: Tezepelumab for treating severe asthma
- NICE HST: Setmelanotide for treating obesity caused by LEPR or POMC deficiency
- NICE STA: Ozanimod for treating moderately to severely active ulcerative colitis
- NICE HST: Givosiran for treating acute hepatic porphyria
- NICE STA: Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 1 prior therapy
Publications
Journal articles
Conferences
Reports
External Engagement and Impact
Awards and Honours
- Summer Undergraduate Research Program (SURP) Fellowship (2009), Dr. B.R. Ambedkar Centre for Biomedical Research (ACBR), University of Delhi, India.
- Robinson scholar of the year (2012/13), Department of Management science, Lancaster University Management School (LUMS), Lancaster University, UK.